1. Introduction {#sec0005}
===============

The imaging diagnostics of liver tumors are difficult. Some cases are not clear whether they are benign or malignant, and they often require ultrasonography (US)-guided biopsy \[[@bib0005], [@bib0010], [@bib0015], [@bib0020], [@bib0025]\]. In cases in which tumors are not detectable by US, computed tomography (CT)-guided biopsy examination is used. However, there are presently no effective biopsy examinations for liver tumors that are undetectable even by using CT-guided biopsy.

We report a case of a focal nodular hyperplasia (FNH)-like nodule showing progression, which did not rule out the possibility of malignancy. The patient could not undergo biopsy of the tumor using US or CT because the tumors were not detectable with any modality except gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI). We performed an excisional biopsy of the tumor using analysis of the liver surface based on the preoperative 3D simulation and visualization. The work has been reported in line with the SCARE criteria \[[@bib0030]\].

2. Presentation of case {#sec0010}
=======================

A 67-year-old man was diagnosed as having type C chronic hepatitis and had been treated at our hospital. After diagnosis, the patient was scheduled for regular follow-up examinations. From October 2009, contrast-enhanced CT and gadolinium-enhanced magnetic resonance imaging (Gd-MRI) were periodically checked; however, no tumor was detected. In April 2014, EOB-MRI was performed for the first time and showed delayed enhanced multiple tumors in the bilateral lobes of the liver. In the hepatobiliary phase, these nodules appeared hyperintense, and the largest nodule had a central scar ([Fig. 1](#fig0005){ref-type="fig"}). Though we checked the contrast-enhanced US with a perflubutane microbubble contrast agent (Sonazoid; Daiichi-Sankyo, Tokyo, Japan), each vascular phase and the Kupffer phase did not clearly show the nodules that had been detected by EOB-MRI. He showed no hepatitis B virus, but hepatitis C virus infection (anti-hepatitis C virus antibody) was positive. The laboratory tests of liver function and tumor markers were all negative.Fig. 1Finding of clinical imaging (the largest tumor in segment 3 of the liver) (A--C) EOB-MRI showed delayed enhanced multiple tumors in the bilateral lobes of the liver. In the hepatobiliary phase, these nodules appeared hyperintense, and (D) the largest nodule had a central scar. (E,F) Dynamic CT did not detect any tumors.Fig. 1

The patient was followed up as an outpatient. Dynamic CT in May 2014 and Gd-MRI in August 2014 were performed, however, other than with EOB-MRI the tumors remained undetectable. EOB-MRI was performed again in March 2015, which showed multiple tumors in the bilateral lobes of the liver had increased in size. The maximum tumor diameter increased from 26 mm to 29 mm. Therefore, the possibility of a malignant tumor could not be ruled out, and a liver biopsy was considered to make a definitive diagnosis.

2.1. Surgical technique {#sec0015}
-----------------------

Tumor tissues are needed to make pathological diagnoses, however, a percutaneous liver biopsy was impossible because neither CT nor US could detect the masses. Therefore, we planned a laparoscopic partial liver excisional biopsy using analysis of the liver surface based on the preoperative 3D simulation and visualization. In order to create preoperative simulations, the volume analyzer SYNAPSE VINCENT by Fujifilm, in its Liver Analysis Application, was used. First, the liver surface was created with the MDCT (multiple detector CT) images employing the 3D region growing image segmentation method. The tumor location was determined by reflecting the information from the EOB-MRI into the 3D simulation ([Fig. 2](#fig0010){ref-type="fig"}). The four noticeable surface irregularity points around the tumor were defined, and we determined that the tumor was completely resected by maintaining the extent of resection including these points at a depth of 2 centimeters.Fig. 2(A,B) The preoperative 3D simulation and visualization was created preoperatively by the SYNAPSE VINCENT. There were multiple tumors in the bilateral lobes of the liver. (C) The salient peripheralis tumor in segment 6 that was detected with MRI imaging in the hepatobiliary phase appeared as the easiest to resect and was therefore selected for resection.Fig. 2

3. Results {#sec0020}
==========

The patient's informed consent was obtained for the surgical procedure. The operative time was 155 min, and blood loss was insignificant. The location of each liver surface tumor was visually indeterminable neither could intraoperative laparoscopic US detect any of the tumors. However, 3D imaging provides accurate information of liver surface irregularities with cirrhotic change. We could, therefore, identify the tumor location and perform an adequate tumor excisional biopsy ([Fig. 3](#fig0015){ref-type="fig"}). Macroscopic findings showed the tumor was 1.2 cm in diameter with a relatively clear margin against the surrounding liver tissue. A soft green nodule was resected with a sufficient surgical margin ([Fig. 4](#fig0020){ref-type="fig"}). In the background liver, the hepatic parenchyma had a noticeable cirrhotic change. The pathological diagnosis of this nodule was an FNH-like nodule.Fig. 3The location of tumors even on the surface were visually indeterminable intraoperatively. Tumor excisional biopsy using the 3D imaging provided accurate information of liver surface irregularities with cirrhotic change. (A) Simulation imaging of the target tumor. (B) The resection line was marked with an electrocautery. The asterisks denote the surface irregularities around the tumor. (C) The appearance after resection.Fig. 3Fig. 4Macroscopic findings showed the tumor was 1.2 cm in diameter with a relatively clear margin against the surrounding liver tissue. (A,B) A soft green nodule was resected with a sufficient surgical margin. In the background liver, the hepatic parenchyma had a noticeable cirrhotic change. (C) The tumoral tissue is seen in the left side of the frame and the normal liver tissue is to the right. Hematoxylin and eosin stain, ×40. Compared with the background liver, the nodule showed higher cellular density. The pathological diagnosis of this nodule was an FNH-like nodule.Fig. 4

The clinical course after partial hepatectomy was good and regular check-ups were performed. Surprisingly, in June 2017, follow-up EOB-MRI showed that each tumor continued to grow.

4. Discussion {#sec0025}
=============

3D imaging is applied in various fields because of its distinct features. With it, it is now easier to understand the depth and the relationship with the surrounding structures compared to that using a conventional 2D image \[[@bib0035]\]. This also holds true in the field of surgery, and 3D simulation and visualization is often used in not only in liver operations but also for organs such as the pancreas and the esophagus \[[@bib0040], [@bib0045]\]. Previous reports focused on the 3D simulation of the vascular anatomy of each organ. However, the 3D simulation of the liver surface architecture was used in the present report. And, to our knowledge, there has not been any other report on this application using 3D simulation.

In a laparotomy approach, a liver excisional biopsy using 3D simulation imaging may be avoided as an alternate method of a percutaneous liver biopsy because of its high invasiveness. However, with a laparoscopic approach, there can be a broad clinical application providing minimally invasiveness, as in the present case. Of course, there are differences of abdominal situations between, for example, the resting state for a CT scan and laparoscopic surgery through the pneumoperitoneum. Furthermore, the intraoperative handling of organs could change the detailed liver figure. However, with regard to the cirrhotic hard liver, the surface architecture is insulated from the influence of such manipulation. The roughness of its surface might also have lead to the positive results in the present case. The background liver, which generated tumors like hepatocellular carcinoma, was generally a hard cirrhotic liver; therefore, this method may prove to be beneficial.

This excision biopsy method has some limitations. First, although it is effective for tumors on or near the surface, it is not applicable for all cases such as deep or central tumors. However, for central tumors, this will be resolved if the following method is used. Use image analysis to determine the positional relationship with the relatively deep noticeable vessels that surround the tumors, and puncture the target tumor or resect the appropriate size for a biopsy. Second, to calculate the resection line that involves the entire tumor is possible with image simulation of the liver surface, however, the cutting and confirmation of the image of the tumor is not done simultaneously. Therefore, the possibility of leaving the tumor stump should be considered. For this reason, at present, this method should only be used in certain cases such as when there is a risk of cutting into the tumor or when a positive margin is permissible. In the future, however, advances of imaging technology may make this method viable for not only tumor biopsies, but also radical excisions for malignant tumors. In this report, we used the preoperative 3D simulation, not real-time navigation. Real-time navigation may enable progression of the simulation and increase surface profile accuracy. Therefore, this surgical method will see improvements in accuracy and safety and will be appropriate as a radical excision method for superficial malignant tumors undetected by CT or US.

Recently, for the tumors that cannot be detected by either CT or US, MRI guided biopsy is done, and its efficiency is recognized in the breast and prostate regions \[[@bib0050], [@bib0055]\]. Regarding liver biopsies, however, the open magnet MRI device is necessary, but its deployment is expensive. The quality of the image is also limited \[[@bib0060]\]; and, the biopsy specimens often require diameters of 3 cm or larger.

A liver needle biopsy can be helpful in liver tumor diagnoses; however, there is the possibility that the biopsy specimens may mistakenly be taken from the surrounding normal tissue and not from a target lesion. Moreover, in pathologically benign liver tumors, it is not uncommon to observe dysplasia resembling normal liver tissues; therefore, it is difficult to determine whether or not the biopsy specimens were accurately taken from a target lesion. Furthermore, needle biopsy for tumors that are potentially malignant present the risk of dissemination. Therefore, partial liver excisional biopsy, as that done in the present report, is safer and more definitive than the commonly used needle biopsy.

Although the excised specimen was compatible with the FNH-like nodule in histopathologically and ruled out malignant disease, the tumors continued to increase in size even after the operation. FNH-like nodules are usually benign tumors that are not premalignant. There are, however, some reports in which the tumors underwent malignant transformation \[[@bib0065]\]. Therefore, regarding the progressive FNH-like nodules for which a risk of malignant transformation cannot be ruled out, as in the present case, a thorough follow-up is warranted.

5. Conclusion {#sec0030}
=============

We reported a case of multiple progressing FNH-like nodules in a man with hepatitis C. In this case, percutaneous liver biopsy was considered impossible because CT and US did not detect the masses. However, laparoscopic partial liver excisional biopsy using analysis of the liver surface based on the preoperative 3D simulation and visualization could provide accurate information of tumor location and an adequate excisional biopsy.
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